carvedilol phosphate capsule extended release
1 INDICATIONS AND USAGE Carvedilol Phosphate extended-release capsules are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: • mild to severe chronic heart failure. ( 1.1 ) • left ventricular dysfunction following myocardial infarction in clinically stable patients. ( 1.2 ) • hypertension. ( 1.3 ) 1.1 Heart Failure Carvedilol Phosphate extended-release capsules are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions ( 7.4 ), Clinical Studies ( 14.1 )] . 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol Phosphate extended-release capsules are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies ( 14.2 )] . 1.3 Hypertension Carvedilol Phosphate extended-release capsules are indicated for the management of essential hypertension [see Clinical Studies ( 14.3 , 14.4 )] . They can be used alone or in combination with other antihypertensive agents, especially thiazide‑type diuretics [see Drug Interactions ( 7.2 )] .
apotex corp.
Related Pills
carvedilol phosphate capsule extended release
apotex corp.
carvedilol phosphate capsule extended release
apotex corp.
carvedilol phosphate capsule extended release
apotex corp.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING The hard gelatin capsules are available in the following strengths: • 10 mg – white and green capsule shell printed with “GSLGK” and “10 mg” • 20 mg – white and yellow capsule shell printed with “GSMHV” and “20 mg” • 40 mg – yellow and green capsule shell printed with “GSETX” and “40 mg” • 80 mg – white capsule shell printed with “GSF1L” and “80 mg” • 10 mg bottles of 30: NDC 60505-4713-3 • 20 mg bottles of 30: NDC 60505-4714-3 • 40 mg bottles of 30: NDC 60505-4715-3 • 80 mg bottles of 30: NDC 60505-4716-3 Store at 25°C (77°F); excursions 15° to 30°C (59° to 86°F). Dispense in a tight, light‑resistant container.
More pills like CAPSULE GSMHV 20mg